.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Cerilliant
Cipla
US Army
AstraZeneca
Moodys
Farmers Insurance
Covington
Deloitte
Citi

Generated: September 24, 2017

DrugPatentWatch Database Preview

Carbinoxamine maleate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for carbinoxamine maleate and what is the scope of carbinoxamine maleate patent protection?

Carbinoxamine maleate
is the generic ingredient in three branded drugs marketed by Vintage Pharms, Ortho Mcneil Pharm, Cypress Pharm, Invagen Pharms, Mikart, Mcneil, Tris Pharma Inc, Mission Pharmacal Co, and Mikart Inc, and is included in twelve NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Carbinoxamine maleate has nineteen patent family members in fourteen countries.

There are seven drug master file entries for carbinoxamine maleate. Eight suppliers are listed for this compound.

Summary for Generic Name: carbinoxamine maleate

Tradenames:3
Patents:2
Applicants:9
NDAs:12
Drug Master File Entries: see list7
Suppliers / Packagers: see list8
Bulk Api Vendors: see list20
Clinical Trials: see list183
Patent Applications: see list987
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:carbinoxamine maleate at DailyMed

Pharmacology for Ingredient: carbinoxamine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tris Pharma Inc
KARBINAL ER
carbinoxamine maleate
SUSPENSION, EXTENDED RELEASE;ORAL022556-001Mar 28, 2013RXYesYes► Subscribe► SubscribeY ► Subscribe
Mcneil
CLISTIN
carbinoxamine maleate
ELIXIR;ORAL008955-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil Pharm
CLISTIN
carbinoxamine maleate
TABLET;ORAL008915-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Cypress Pharm
CARBINOXAMINE MALEATE
carbinoxamine maleate
SOLUTION;ORAL090418-001May 4, 2010AARXNoNo► Subscribe► Subscribe► Subscribe
Mikart
CARBINOXAMINE MALEATE
carbinoxamine maleate
SOLUTION;ORAL040458-001Apr 25, 2003AARXNoYes► Subscribe► Subscribe► Subscribe
Cypress Pharm
CARBINOXAMINE MALEATE
carbinoxamine maleate
TABLET;ORAL090417-001Aug 23, 2010AARXNoNo► Subscribe► Subscribe► Subscribe
Mikart Inc
CARBINOXAMINE MALEATE
carbinoxamine maleate
TABLET;ORAL207484-001May 31, 2016RXNoNo► Subscribe► Subscribe► Subscribe
Mission Pharmacal Co
CARBINOXAMINE MALEATE
carbinoxamine maleate
TABLET;ORAL090756-001May 27, 2011AARXNoNo► Subscribe► Subscribe► Subscribe
Vintage Pharms
CARBINOXAMINE MALEATE
carbinoxamine maleate
TABLET;ORAL040639-002May 30, 2008AARXNoNo► Subscribe► Subscribe► Subscribe
Invagen Pharms
CARBINOXAMINE MALEATE
carbinoxamine maleate
TABLET;ORAL090435-001Apr 15, 2010AARXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: carbinoxamine maleate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,675,704Modified release formulations containing drug-ion exchange resin complexes► Subscribe
8,202,537Modified release formulations containing drug-ion exchange resin complexes► Subscribe
8,747,902Modified release formulations containing drug-ion exchange resin complexes► Subscribe
8,597,684Modified release formulations containing drug-ion exchange resin complexes► Subscribe
8,491,935Modified release formulations containing drug-ion exchange resin complexes► Subscribe
9,675,703Modified release formulations containing drug - ion exchange resin complexes► Subscribe
9,198,864Modified release formulations containing drug-ion exchange resin complexes► Subscribe
9,549,989Modified release formulations containing drug-ion exchange resin complexes► Subscribe
8,337,890Modified release formulations containing drug-ion exchange resin complexes► Subscribe
8,883,217Modified release formulations containing drug-ion exchange resin complexes► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: carbinoxamine maleate

Country Document Number Estimated Expiration
Spain2396039► Subscribe
Australia2007227569► Subscribe
BrazilPI0709606► Subscribe
Denmark2428205► Subscribe
World Intellectual Property Organization (WIPO)2007109104► Subscribe
Japan5479086► Subscribe
Russian Federation2435569► Subscribe
South Korea20080108520► Subscribe
European Patent Office2018160► Subscribe
Denmark2018160► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
QuintilesIMS
Julphar
Citi
McKesson
Mallinckrodt
Queensland Health
Novartis
Chinese Patent Office
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot